Baclofen and 2-hydroxysaclofen modify acute hypolocomotive and antinociceptive effects of nicotine

European Journal of Pharmacology

Volumn 738, Issue , 2014, Pages 200-205

  Varani, Andrés P ^a   Aso, Ester ^b,d   Maldonado, Rafael ^b   Balerio, Graciela N ^a,c  

^a Instituto de Investigaciones Farmacologicas   (Argentina)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

2 hydroxysaclofen; Baclofen; Locomotion; Nicotine; Nociception

Indexed keywords

2 HYDROXYSACLOFEN; 4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; NICOTINE TARTRATE; 2-HYDROXYSACLOFEN; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; NICOTINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; HYPOACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL IMMERSION TEST; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; DRUG INTERACTION; MOTOR ACTIVITY;

ANALGESICS; ANIMALS; BACLOFEN; DRUG INTERACTIONS; GABA-B RECEPTOR AGONISTS; GABA-B RECEPTOR ANTAGONISTS; MALE; MICE; MOTOR ACTIVITY; NICOTINE;

EID: 84902301851     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.05.039     Document Type: Article

References (41)

1. J.H. Abraini, B. Kriem, N. Balon, J.C. Rostain, and J.J. Risso Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide Anesth. Analg. 96 3 2003 746 749 (Pubitemid 36245563)
2. G.N. Balerio, and M.C. Rubio Baclofen analgesia: involvement of the GABAergic system Pharmacol. Res. 46 3 2002 281 286 (Pubitemid 35300768)
3. A.W. Bannon, M.W. Decker, M.W. Holladay, P. Curzon, D. Donnelly-Roberts, P.S. Puttfarcken, R.S. Bitner, A. Diaz, A.H. Dickenson, R.D. Porsolt, M. Williams, and S.P. Arneric Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors Science 279 1998 77 81 (Pubitemid 28079158)
4. E.A. Barnard, P. Skolnick, R.W. Olsen, H. Mohler, W. Sieghart, G. Biggio, C. Braestrup, A.N. Bateson, and S.Z. Langer International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function Pharmacol. Rev. 50 1998 291 313 (Pubitemid 28304030)
5. F. Berrendero, B.L. Kieffer, and R. Maldonado Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice J. Neurosci. 22 24 2002 10935 10940 (Pubitemid 36005169)
6. F. Berrendero, V. Mendizábal, P. Robledo, L. Galeote, A. Bilkei-Gorzo, A. Zimmer, and R. Maldonado Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene J. Neurosci. 25 5 2005 1103 1112 (Pubitemid 40268951)
7. F. Berrendero, P. Robledo, J.M. Trigo, E. Martín-García, and R. Maldonado Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system Neurosci. Biobehav. Rev. 35 2 2010 220 231
8. Y.A. Blednov, M. Stoffel, H. Alva, and R.A. Harris A pervasive mechanism for analgesia: activation of GIRK2 channels Proc. Natl. Acad. Sci. USA 100 1 2003 277 282 (Pubitemid 36078065)
9. N.G. Bowery, B. Bettler, W. Froestl, J.P. Gallagher, F. Marshall, M. Raiteri, T.I. Bonner, and S.J. Enna International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function Pharmacol. Rev. 54 2002 247 264 (Pubitemid 34575715)
10. A.R. Caggiula, L.H. Epstein, K.A. Perkins, and S. Saylor Different methods of assessing nicotine-induced antinociception may engage different neuronal mechanisms Psychopharmacology 122 1995 301 306
11. A. Castañé, E. Valjent, C. Ledent, M. Parmentier, R. Maldonado, and O. Valverde Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence Neuropharmacology 43 2002 857 867 (Pubitemid 35221396)
12. W.A. Corrigall, K.M. Coen, K.L. Adamson, and J.Z. Chow Response of nicotine self-administration in the rat to manipulations of mu-opioid and γ-aminobutyric acid receptors in the ventral tegmental area Psychopharmacology (Berl) 149 2000 107 114 (Pubitemid 30238947)
13. (B) receptor agonists for the treatment of drug addiction: a review of recent findings Drug Alcohol Depend. 65 3 2002 209 220 (Pubitemid 34159068)
14. J.A. Dani, and D.J. Balfour Historical and current perspective on tobacco use and nicotine addiction Trends Neurosci. 34 7 2011 383 392
15. L. Fattore, G. Cossu, M.C. Martellotta, and W. Fratta Baclofen antagonizes intravenous self-administration of nicotine in mice and rats Alcohol Alcohol. 37 5 2002 495 498
16. L. Fattore, M.S. Spano, G. Cossu, M. Scherma, W. Fratta, and P. Fadda Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents Eur. Neuropsychopharmacol. 19 2009 487 498
17. B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study Drug Alcohol Depend. 103 1-2 2009 30 36
18. B receptor ligands in animal tests of depression and anxiety Pharmacol. Rep. 59 6 2007 645 655 (Pubitemid 351586555)
19. L. Galeote, B.L. Kieffer, R. Maldonado, and F. Berrendero Mu-opioid receptors are involved in the tolerance to nicotine antinociception J. Neurochem. 97 2 2006 416 423
20. L. Galeote, R. Maldonado, and F. Berrendero Involvement of kappa/dynorphin system in the development of tolerance to nicotine-induced antinociception J. Neurochem. 105 2008 1358 1368 (Pubitemid 351590804)
21. B receptor stimulation accentuates the locomotor effects of morphine in mice bred for extreme sensitivity to the stimulant effects of ethanol Pharmacol. Biochem. Behav. 85 4 2006 697 704 (Pubitemid 46151718)
22. N. Imamachi, G.H. Park, H. Lee, D.J. Anderson, M.I. Simon, A.I. Basbaum, and S.K. Han TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms Proc. Natl. Acad. Sci. USA 106 2009 11330 11335
23. E.T. Iwamoto Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus J. Pharmacol. Exp. Ther. 257 1991 120 133
24. P.W. Kalivas, D. Jackson, A. Romanidies, L. Wyndham, and P. Duffy Involvement of pallidothalamic circuitry in working memory Neuroscience 104 1 2001 129 136 (Pubitemid 32322619)
25. B. Le Foll, C.E. Wertheim, and S.R. Goldberg Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats Neurosci. Lett. 443 3 2008 236 240
26. A. Markou, N.E. Paterson, and S. Semenova Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation Ann. N. Y. Acad. Sci. 1025 2004 491 503 (Pubitemid 39643899)
27. B receptors: the first 7TM heterodimers Trends Pharmacol. Sci. 20 1999 396 399 (Pubitemid 29450359)
28. H.W. Matthes, R. Maldonado, F. Simonin, O. Valverde, S. Slowe, I. Kitchen, K. Befort, A. Dierich, M. Le Meur, P. Dollé, E. Tzavara, J. Hanoune, B.P. Roques, and B.L. Kieffer Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene Nature 383 6603 1996 819 823
29. N.S. Millar, and C. Gotti Diversity of vertebrate nicotinic acetylcholine receptors Neuropharmacology 56 2009 237 246
30. B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat Psychopharmacology (Berl) 172 2 2004 179 186 (Pubitemid 38388767)
31. N.E. Paterson The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine Behav. Pharmacol. 20 3 2009 211 225
32. M.R. Picciotto, and W.A. Corrigall Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics J. Neurosci. 22 2002 3338 3341 (Pubitemid 37465738)
33. M. Rubinstein, J.S. Mogil, M. Japón, E.C. Chan, R.G. Allen, and M.J. Low Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis Proc. Natl. Acad. Sci. USA 93 1996 3995 4000 (Pubitemid 26144234)
34. SENASA (Resolución 617/2002): Requisitos, condiciones y procedimientos para la habilitación técnica de laboratorios que posean bioterios de producción, mantenimiento y local de experimentación.
35. F. Simonin, O. Valverde, C. Smadja, S. Slowe, I. Kitchen, A. Dierich, M. Le Meur, B.P. Roques, R. Maldonado, and B.L. Kieffer Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal EMBO J. 17 1998 886 897 (Pubitemid 28077643)
36. J.M. Trigo, A. Zimmer, and R. Maldonado Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin Neuropharmacology 56 2009 1147 1153
37. E. Valjent, J.M. Mitchell, M.J. Besson, J. Caboche, and R. Maldonado Behavioral and biochemical evidence for interactions between delta 9-tetrahydrocannabinol and nicotine Br. J. Pharmacol. 135 2 2002 564 578 (Pubitemid 34151189)
38. Varani A.P., Aso E., Moutinho Machado L., Maldonado R. and Balerio G.N., Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations, Psychopharmacology (Berl), 10.1007/s00213-014-3469-6, in press (Epub ahead of print)
39. B receptors involvement in the effects induced by nicotine on anxiety-related behaviour in mice Pharmacol. Res. 65 2012 507 513
40. (B1) knockout mice Neuropharmacology 63 2012 863 872
41. A.P. Varani, L. Moutinho Machado, M. Calvo, and G.N. Balerio Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal Drug Alcohol Depend. 119 2011 5 12